1. Home
  2. WEYS vs ACHV Comparison

WEYS vs ACHV Comparison

Compare WEYS & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$30.32

Market Cap

280.9M

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.49

Market Cap

239.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
ACHV
Founded
1906
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.9M
239.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WEYS
ACHV
Price
$30.32
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
15.0K
577.5K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
2.54
N/A
Revenue
$279,843,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.51
$1.84
52 Week High
$37.25
$5.78

Technical Indicators

Market Signals
Indicator
WEYS
ACHV
Relative Strength Index (RSI) 49.60 67.56
Support Level $30.13 $4.30
Resistance Level $31.82 $5.28
Average True Range (ATR) 0.95 0.27
MACD -0.22 0.09
Stochastic Oscillator 25.29 95.38

Price Performance

Historical Comparison
WEYS
ACHV

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: